Eltrombopag Ethyl Ester Impurity
✓
データの正確性100%
24時間年中無休の科学サポート
⬡
品質に対する妥協ゼロ

在庫拠点

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート(SER)、および製品に応じた追加分析データ。

3077185-45-3Eltrombopag Ethyl Ester Impurity

● 在庫あり

カタログ番号:VE0028252
CAS番号:3077185-45-3
分子式:C27H26N4O4
分子量:470.52 g/mol

に関する追加情報 CAS 3077185-45-3

親薬物

Eltrombopag

IUPAC名

(ethyl (Z)-3′-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2′-hydroxy-[1,1′- biphenyl]-3-carboxylate)

Pharmacopeial Synonyms

N/A

同義語

N/A

SMILES

O=C(C1=CC=CC(C2=CC=CC(N/N=C3C(C)=NN(C4=CC(C)=C(C)C=C4)C/3=O)=C2O)=C1)OCC

InChI

InChI=1S/C27H26N4O4/c1-5-35-27(34)20-9-6-8-19(15-20)22-10-7-11-23(25(22)32)28-29-24-18(4)30-31(26(24)33)21-13-12-16(2)17(3)14-21/h6-15,28,32H,5H2,1-4H3/b29-24-

説明

Eltrombopag Ethyl Ester Impurity (CAS 3077185-45-3) is a process-related impurity arising from ethyl esterification steps of eltrombopag synthesis that requires focused control within the API impurity profile. This impurity can compromise drug substance purity and long term stability and is typically monitored by validated HPLC-UV assays supported by LC-MS for mass confirmation and NMR for structural assignment. Effective control is achieved through optimized reaction conditions, targeted purification and in-process controls to minimize formation and carryover. Establishing qualification thresholds, stability indicating methods and documentation in line with ICH guidelines ensures robust identification, quantitation and regulatory compliance.

見積もり依頼

「*」は必須フィールドを示します

このフィールドは入力チェック用です。変更しないでください。
Products quotation
Name
Url